iRhythm Technologies Inc (IRTC) - Total Liabilities
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has total liabilities worth $845.15 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore iRhythm Technologies Inc (IRTC) investment intensity to see how much of total assets are deployed in long-term investments.
iRhythm Technologies Inc - Total Liabilities Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of iRhythm Technologies Inc.
iRhythm Technologies Inc Competitors by Total Liabilities
The table below lists competitors of iRhythm Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fosun International Limited
F:FNI
|
Germany | €547.93 Billion |
|
WSFS Financial Corporation
NASDAQ:WSFS
|
USA | $18.59 Billion |
|
PTC INDUSTRIES LTD
NSE:PTCIL
|
India | Rs4.49 Billion |
|
FIT Hon Teng Limited
F:0FJ
|
Germany | €3.18 Billion |
|
Granite Real Estate Investment Trust
TO:GRT-UN
|
Canada | CA$4.04 Billion |
|
Ideaya Biosciences Inc
NASDAQ:IDYA
|
USA | $110.79 Million |
|
Monday.Com Ltd
NASDAQ:MNDY
|
USA | $933.51 Million |
|
Charoen Pokphand Foods Public Company Limited
F:NVAV
|
Germany | €609.94 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down iRhythm Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See iRhythm Technologies Inc (IRTC) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.84 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how iRhythm Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for iRhythm Technologies Inc (2013–2025)
The table below shows the annual total liabilities of iRhythm Technologies Inc from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $867.30 Million | +3.18% |
| 2024-12-31 | $840.54 Million | +276.84% |
| 2023-12-31 | $223.05 Million | +7.02% |
| 2022-12-31 | $208.41 Million | +13.60% |
| 2021-12-31 | $183.45 Million | +7.83% |
| 2020-12-31 | $170.13 Million | -0.40% |
| 2019-12-31 | $170.80 Million | +161.61% |
| 2018-12-31 | $65.29 Million | +21.87% |
| 2017-12-31 | $53.57 Million | +17.49% |
| 2016-12-31 | $45.59 Million | -67.32% |
| 2015-12-31 | $139.50 Million | +1140.52% |
| 2014-12-31 | $11.24 Million | +29.80% |
| 2013-12-31 | $8.66 Million | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more